Infant formula food for improving bioavailability of stable amino acid and application of infant formula food
By adding α-lactalbumin, linoleic acid, and prebiotics to infant formula and controlling their mass ratio, the problems of poor protein digestion and low amino acid absorption in infants and young children are solved, the bioavailability of amino acids is improved, and healthy growth of infants and young children is promoted.
Patent Information
- Application Number
- CN202410960977.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-17
- Publication Date
- 2024-11-08
AI Technical Summary
Infants and young children often experience digestive problems and low amino acid absorption rates due to poor protein digestion, which affects their growth and development. Currently available infant formula foods have low amino acid bioavailability.
Adding α-lactalbumin, linoleic acid, and prebiotics to infant formula, with a mass ratio of (0.25-0.6):1:(0.1-0.96), can improve the bioavailability of amino acids.
It improves the digestibility and absorption of amino acids in infant formula, especially valine, leucine, isoleucine, threonine, lysine, and histidine, promoting healthy growth.
Smart Images

Figure BDA0004950252880000131 
Figure HDA0004950252890000011 
Figure HDA0004950252890000012
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of infant formula food, and specifically relates to an infant formula food containing alpha-lactalbumin, linoleic acid and prebiotics and capable of improving the bioavailability of stable amino acids, and related applications. Background Art
[0002] Infancy is the fastest growth and development stage after the fetal period, and sufficient nutrients are needed to maintain vigorous metabolism and growth and development. Protein is an important nutrient for the growth and development of infants and young children. Protein intake in early infancy is crucial to the health of infants and young children, affecting growth, body composition, neurodevelopment, appetite and hormone regulation. Protein digestion problems can lead to short-term and long-term adverse consequences, such as pain, diarrhea, intolerance, allergies, malabsorption and constipation. Studies have shown that developmental delay in early childhood is associated with low levels of essential amino acids circulating in the body. After increasing serum amino acids (especially branched-chain amino acids), the height-age Z score of young children has significantly improved. However, the higher the protein intake, the better. Some studies have also pointed out that high protein intake in early life is associated with overweight, obesity and chronic disease prevalence in adulthood, but the underlying mechanism still needs to be further explored. Therefore, ensuring proper protein digestion and intake is essential to support the healthy growth of infants.
[0003] However, the gastrointestinal tract of newborns is not fully developed, the digestive tract is short, the secretion of digestive juices and the activity of digestive enzymes are low, and the microbial flora is still in the stage of gradual establishment. The ability of infants and young children to digest food, especially protein nutrients, is far less than that of adults. Comparing the digestive environment of the gastrointestinal tract of adults and infants and young children, it was found that in the fasting state, the gastric pH of newborns is about 3.0-4.0. As the age of the infant increases, the gastric pH can drop to 1.5-3.0, but there is still a certain difference from the 1.7-1.9 of the adult stomach. After ingesting food, the stomach pH of infants and young children is about 5.59, which is also higher than the pH of adults after eating. The activity of pepsin, which is responsible for hydrolyzing protein in the stomach, is only 18% of that of adults in infancy. Under the high pH of the stomach of infants and young children, the degree of protein digestion in the stomach of infants and young children is limited. The intestine is the main digestion site of protein. Protein is broken down into amino acids and small molecule peptides by digestive enzymes such as trypsin in the intestine. However, an immature intestine reduces the protein digestibility. In addition, because the intestinal tract and its barrier are immature in infants and young children, the intestinal mucosal cells are sparsely arranged, and the intestinal wall is highly permeable, unhydrolyzed protein molecules may pass through the intestinal mucosa and cause allergic reactions, diarrhea, and intestinal reflux, affecting the growth and development of infants and young children. In addition, lipids and dietary fiber in the diet may also affect the digestion and absorption of protein.
[0004] Amino acids are the building blocks of proteins and are essential nutrients for the growth and development of infants and young children. According to whether they can be synthesized in the body, amino acids can be divided into essential amino acids and non-essential amino acids. Essential amino acids cannot be synthesized in the human body or the synthesis rate cannot meet the needs of the body and must be obtained from the diet, including: isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine and histidine. Non-essential amino acids can be synthesized by the human body and do not need to be obtained from the diet, including aspartic acid, glutamic acid, glycine, proline, serine, cysteine and tyrosine. Different food proteins differ in the types and contents of essential amino acids, which can be characterized by amino acid patterns.
[0005] The amino acid composition of cow's milk protein is quite different from that of breast milk, which makes the protein quality of infant formula foods with cow's milk as the main protein source relatively low, and the bioavailability of amino acids is low. Therefore, it is necessary to make targeted adjustments and optimizations when developing infant formula foods to improve protein quality, improve the bioavailability of amino acids, and promote amino acids to be more conducive to infant absorption. Summary of the invention
[0006] An object of the present invention is to provide an infant formula food which can improve the bioavailability of stable amino acids.
[0007] Another object of the present invention is to provide related applications of the infant formula food in improving the bioavailability of stable amino acids.
[0008] On the one hand, the present invention provides an infant formula food, which contains α-lactalbumin, linoleic acid and prebiotics, and the mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.25-0.6):1:(0.1-0.96).
[0009] α-lactalbumin (also known as α-whey protein) is a calcium-binding protein in the breast milk of mammals and humans, accounting for 20% to 25% of the total protein in breast milk. Its structure is similar to lysozyme, and it is rich in essential amino acids such as lysine, leucine, isoleucine, cysteine and tryptophan. It has multiple nutritional and health functions and has broad application and development prospects in food production.
[0010] According to a specific embodiment of the present invention, the infant formula food of the present invention can be a liquid food or a solid food (that is, the infant formula food can be an infant formula powder or a toddler formula powder). The infant formula food of the present invention can be a common food, a health food or an infant formula food for special medical purposes.
[0011] According to a specific embodiment of the present invention, in the infant formula food of the present invention, the raw material for providing the α-lactalbumin of the present invention may be whey protein powder, for example, whey protein powder from cow's milk and / or goat's milk. Preferably, the content of α-lactalbumin in such raw material powder is not less than 40%.
[0012] According to a specific embodiment of the present invention, in the infant formula food of the present invention, α-lactalbumin accounts for 8%-100% of the total protein content in the food.
[0013] According to some specific embodiments of the present invention, in the infant formula food of the present invention, α-lactalbumin accounts for 8%-80% of the total protein content in the food.
[0014] According to some specific embodiments of the present invention, in the infant formula food of the present invention, α-lactalbumin accounts for 8%-60% of the total protein content in the food.
[0015] According to some specific embodiments of the present invention, in the infant formula food of the present invention, α-lactalbumin accounts for 8%-30% of the total protein content in the food.
[0016] According to some specific embodiments of the present invention, in the infant formula food of the present invention, α-lactalbumin accounts for 8%-22% of the total protein content in the food.
[0017] According to some specific embodiments of the present invention, in the infant formula food of the present invention, α-lactalbumin accounts for 8%-21% of the total protein content in the food.
[0018] According to some specific embodiments of the present invention, in the infant formula food of the present invention, α-lactalbumin accounts for 10%-21% of the total protein content in the food.
[0019] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the α-lactalbumin content is 1.0-2.5 g / 100 g food dry matter, preferably 1.5-2.3 g / 100 g food dry matter.
[0020] According to a specific embodiment of the present invention, in the infant formula food of the present invention, the linoleic acid can be obtained from conventional commercial sources, for example, it can be provided by conventional commercial mono- and di-glycerol fatty acid greases.
[0021] According to a specific embodiment of the present invention, in the infant formula food of the present invention, linoleic acid accounts for 10%-50% of the total fat content in the food, preferably 10%-20%.
[0022] According to some specific embodiments of the present invention, the linoleic acid content of the infant formula food of the present invention is 2700-6000 mg / 100 g in terms of dry matter.
[0023] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the prebiotics can be selected from oligosaccharides with a degree of polymerization of 3-10.
[0024] According to a specific embodiment of the present invention, in the infant formula food of the present invention, the prebiotics include one or more of galacto-oligosaccharides (GOS), fructo-oligosaccharides (FOS), fucosyllactose (e.g., 2'-fucosyllactose, 2'-FL or 2-F), and neutral oligosaccharides without fucosylation or sialic acid. The neutral oligosaccharides may include, for example, one or more of lactose-N-neotetraose (LNnT) or lactose-N-tetraose (LNT). Preferably, the prebiotics are selected from one or a combination of two of GOS, FOS, 2'-FL and LNnT. The prebiotics may be conventional food-grade prebiotics.
[0025] In some specific embodiments of the present invention, in the infant formula food of the present invention, the prebiotic is GOS.
[0026] In some specific embodiments of the present invention, in the infant formula food of the present invention, the prebiotic is FOS.
[0027] In some specific embodiments of the present invention, in the infant formula food of the present invention, the prebiotic is a composition comprising GOS and FOS, which can be compounded in a mass ratio of (1-10):(10-1). Preferably, GOS and FOS can be compounded in a mass ratio of (0.5-10):1.
[0028] In some specific embodiments of the present invention, in the infant formula food of the present invention, the prebiotic is a composition comprising 2'-FL and LNnT, which can be compounded in a mass ratio of (1-10): (10-1). Preferably, 2'-FL and LNnT can be compounded in a mass ratio of (1-10): 1, more preferably in a mass ratio of (2-5): 1.
[0029] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the content of prebiotics is: 0.5g-4.8g / 100g food dry matter.
[0030] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the content of prebiotics is: 0.5g-3g / 100g food dry matter.
[0031] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the content of prebiotics is: 0.8g-3g / 100g food dry matter.
[0032] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the content of prebiotics is 2g-3g / 100g food dry matter.
[0033] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.30-0.60):1:(0.12-0.96).
[0034] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.30-0.55):1:(0.15-0.96).
[0035] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.30-0.55):1:(0.15-0.8).
[0036] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.32-0.55):1:(0.15-0.7).
[0037] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.40-0.55):1:(0.15-0.7).
[0038] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.32-0.55):1:(0.25-0.7).
[0039] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.30-0.55):1:(0.38-0.7).
[0040] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.40-0.55):1:(0.42-0.70).
[0041] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.40-0.55):1:(0.50-0.70).
[0042] According to some specific embodiments of the present invention, in the infant formula food of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.50-0.55):1:(0.60-0.68).
[0043] According to a specific embodiment of the present invention, the infant formula food of the present invention, in addition to the α-lactalbumin, linoleic acid and prebiotics, may also include other components of conventional infant formula food, mainly including protein, oil, carbohydrates and the like.
[0044] According to a specific embodiment of the present invention, the total protein content of the infant formula food of the present invention is 8g-22g / 100g, the proportion of whey protein in the total protein is 40%-75%, the fat content is 15g-33g / 100g, and the carbohydrate content is 50g-70g / 100g. Preferably, the total protein content of the infant formula food is 10g-18g / 100g, the proportion of whey protein in the total protein is 40%-70%, the fat content is 18g-30g / 100g, and the carbohydrate content is 52g-60g / 100g.
[0045] According to a specific embodiment of the present invention, the infant formula food of the present invention may further contain linolenic acid. In some specific embodiments of the present invention, the infant formula food has an α-linolenic acid content of 270 to 600 mg / 100 g in terms of dry matter.
[0046] According to some specific embodiments of the present invention, in the present invention, the infant formula is an infant formula for infants aged 0-6 months, a larger infant formula for infants aged 6-12 months, or a toddler formula for children aged 12-36 months.
[0047] According to some specific embodiments of the present invention, in the present invention, the total protein content of the infant formula food for infants aged 0-6 months is 8-15g / 100g, preferably 10-15g / 100g, the proportion of whey protein in the total protein is 60-75%, the fat content is 23-30g / 100g, the linoleic acid content is 2700-6000mg / 100g, the α-linolenic acid content is 270-600mg / 100g, and the carbohydrate content is 50-60g / 100g.
[0048] According to some specific embodiments of the present invention, in the present invention, the total protein content of the formula food for older infants aged 6-12 months is 8-20g / 100g, preferably 10-20g / 100g, the proportion of whey protein in the total protein is 40-75%, the fat content is 20-30g / 100g, the linoleic acid content is 2700-4500mg / 100g, the α-linolenic acid content is 270-450mg / 100g, and the carbohydrate content is 50-60g / 100g.
[0049] According to some specific embodiments of the present invention, in the present invention, the total protein content of the infant formula food for infants aged 12-36 months is 8-20g / 100g, preferably 10-20g / 100g, the fat content is 20-30g / 100g, the linoleic acid content is 2700-4500mg / 100g, the α-linolenic acid content is 270-450mg / 100g, and the carbohydrate content is 50-60g / 100g.
[0050] According to a specific embodiment of the present invention, the raw materials providing total protein in the infant formula food of the present invention may include: one or more of raw milk (cow / sheep), whole milk powder (cow / sheep), skimmed milk powder (cow / sheep), whey protein powder (cow / sheep), desalted whey powder (cow / sheep), etc.
[0051] According to a specific embodiment of the present invention, the raw materials providing fat in the infant formula food of the present invention may include: raw milk (cow / sheep), whole milk powder (cow / sheep), light cream (cow / sheep), corn oil, soybean oil, sunflower oil, 1,3-dioleyl-2-palmityl triglyceride, coconut oil, low-erucic acid rapeseed oil, linseed oil, etc. One or more.
[0052] According to a specific embodiment of the present invention, in the infant formula food of the present invention, the raw materials providing carbohydrates include: lactose and / or the above-mentioned protein raw materials containing lactose (raw milk, whole milk powder, etc.) or non-lactose source substances.
[0053] According to a specific embodiment of the present invention, in addition to the above components, the infant formula food of the present invention may also include conventional components of infant formula food, for example, it may also include one or more of nutrients (vitamins, minerals), dietary fiber, inositol, taurine, L-carnitine, docosahexaenoic acid, eicosatetraenoic acid, lutein, nucleotides, animal Bifidobacterium lactis subsp., lactoferrin, etc. The source, content and usage of these substances should comply with the national standards for infant formula food and relevant regulations.
[0054] In some specific embodiments of the present invention, the infant formula food of the present invention can be prepared by adding / adjusting α-lactalbumin, linoleic acid and prebiotics to the basic infant formula food. After the infant formula food of the present invention is prepared, the content of α-lactalbumin, linoleic acid and prebiotics can be determined using methods specified in relevant standards or conventional methods in the field, such as high performance liquid chromatography detection and analysis technology.
[0055] According to some specific embodiments of the present invention, the raw material composition of the infant formula food of the present invention includes:
[0056] Raw cow's milk (partially skimmed): provides basic milk protein and fat source.
[0057] Whey and / or whey concentrate (in liquid or powder form): Provides high quality whey protein.
[0058] Edible vegetable blended oil (may contain 1,3-dioleyl-2-palmityl triglyceride): provides essential fatty acids.
[0059] Lactose: serves as the main carbohydrate source.
[0060] Minerals, trace elements, vitamins: provide necessary nutrients to maintain the comprehensive nutritional needs of infants and young children.
[0061] α-Lactalbumin: Provides high-quality protein.
[0062] Linoleic Acid: Provides essential fatty acids.
[0063] Prebiotics (such as galacto-oligosaccharides, fructo-oligosaccharides, fucoidan, etc.): provide support for intestinal health.
[0064] According to some specific embodiments of the present invention, the raw material composition of the infant formula food of the present invention includes the following raw materials in parts by weight:
[0065] Raw milk: 700-3700 parts (e.g. 800 parts, 1000 parts)
[0066] Whey powder: 0-600 parts (can be converted into the corresponding amount of whey liquid, for example: 300 parts, 200 parts)
[0067] Whey protein powder: 0-100 parts (can be converted into the corresponding amount of whey protein liquid, for example: 32 parts, 25 parts)
[0068] Edible vegetable blended oil: 80-240 parts (e.g. 230 parts, 180 parts)
[0069] Lactose: 0-550 parts (e.g. 200 parts, 245 parts)
[0070] Minerals: 8-30 parts (e.g. 18 parts, 15 parts)
[0071] Trace elements: 0.5-2 parts (for example: 1 part, 1.5 parts)
[0072] Vitamins: 2.5-10 parts (for example: 5 parts, 6 parts).
[0073] According to some specific embodiments of the present invention, the infant formula food of the present invention, calculated on a basis of 100 parts by weight of dry matter, comprises the following raw materials:
[0074] α-lactalbumin added to the formula: 0.625-3 parts (e.g. 1.75 parts, 1.5 parts)
[0075] Linoleic acid added to the formula: 2.5-5 parts (e.g. 5 parts, 4 parts)
[0076] Prebiotics added to the formula: 0.25-4.8 parts (for example: 4 parts, 3.8 parts).
[0077] In some specific embodiments of the present invention, the infant formula food of the present invention can be prepared according to the following method: adopt a wet method or a dry method or a dry-wet composite production process to mix α-lactalbumin, linoleic acid and prebiotics with other raw materials in the formula to prepare the infant formula food.
[0078] In some specific embodiments, the preparation process of infant formula mainly includes: homogenization, pasteurization, spray drying (milk powder), UHT sterilization (liquid milk), etc. In some more specific embodiments, the preparation process of infant formula mainly includes: the mixed material is homogenized after filtering and removing impurities, the homogenization temperature is not less than 50°C, and the pressure is not less than 120bar. Subsequently, the homogenized material is concentrated, and the dry matter weight content of the concentrate is 40% to 60%. The concentrated material is sterilized at above 80°C for 10 to 60 seconds. The sterilized material is dried by a spray drying tower (inlet air temperature 150°C to 200°C, exhaust air temperature 80°C to 120°C, negative pressure -10 to -2mmWG, high pressure pump pressure 140 to 250bar), and then introduced into a fluidized bed for secondary drying to obtain a powder.
[0079] On the other hand, the present invention also provides the use of a composition comprising α-lactalbumin, linoleic acid and prebiotics in the preparation of an infant formula food with improved bioavailability of stable amino acids, wherein the infant formula food is any of the aforementioned infant formula foods of the present invention.
[0080] According to a specific embodiment of the present invention, in the present invention, the stable amino acids include one or more of glycine, alanine, valine, leucine, isoleucine, proline, serine, aspartic acid, glutamic acid, threonine, arginine, lysine and histidine; preferably include one or more of valine, leucine, isoleucine, proline, threonine, lysine and histidine; more preferably include one or more of valine, leucine, isoleucine, threonine, lysine and histidine.
[0081] According to a specific embodiment of the present invention, in the present invention, the improved bioavailability of stable amino acids includes improving the digestibility and / or absorption utilization of one or more of glycine, alanine, valine, leucine, isoleucine, proline, serine, aspartic acid, glutamic acid, threonine, arginine, lysine and histidine. Preferably, the improved bioavailability of stable amino acids includes improving the digestibility and / or absorption utilization of one or more of valine, leucine, isoleucine, proline, threonine, lysine and histidine. More preferably, the improved bioavailability of stable amino acids includes improving the digestibility and / or absorption utilization of any one of valine, leucine, isoleucine, threonine, lysine and histidine, or improving the total digestibility and / or absorption utilization of these amino acids.
[0082] On the other hand, the present invention also provides a method for improving the bioavailability of stable amino acids in infant formula, wherein the infant formula is any of the infant formulas described above in the present invention, and the method comprises: controlling the contents of α-lactalbumin, linoleic acid and prebiotics in the infant formula so that the mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.25-0.6):1:(0.1-0.96). Preferably, the mass ratio of α-lactalbumin, linoleic acid and prebiotics is controlled within the more specific scope of the present invention described above.
[0083] In some specific embodiments of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics in infant formula is controlled to be (0.30-0.60):1:(0.12-0.96).
[0084] In some specific embodiments of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics in infant formula is controlled to be (0.30-0.55):1:(0.15-0.96).
[0085] In some specific embodiments of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics in infant formula is controlled to be (0.30-0.55):1:(0.15-0.8).
[0086] In some specific embodiments of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics in infant formula is controlled to be (0.32-0.55):1:(0.15-0.7).
[0087] In some specific embodiments of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics in infant formula is controlled to be (0.40-0.55):1:(0.15-0.7).
[0088] In some specific embodiments of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics in infant formula is controlled to be (0.32-0.55):1:(0.25-0.7).
[0089] In some specific embodiments of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics in infant formula is controlled to be (0.30-0.55):1:(0.38-0.7).
[0090] In some specific embodiments of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics in infant formula is controlled to be (0.40-0.55):1:(0.42-0.70).
[0091] In some specific embodiments of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics in infant formula is controlled to be (0.40-0.55):1:(0.50-0.70).
[0092] In some specific embodiments of the present invention, the mass ratio of α-lactalbumin, linoleic acid and prebiotics in infant formula is controlled to be (0.50-0.55):1:(0.60-0.68).
[0093] In some specific embodiments of the present invention, the present invention investigates the effect of a composition of α-lactalbumin, linoleic acid and prebiotics on the digestive bioavailability of stable amino acids in a piglet model experiment. First, the changes in piglet weight were tracked to confirm that the test formula had no effect on the growth and development of piglets. Subsequently, the amino acid composition of the test groups was determined, and there was basically no significant difference among the four groups of test formulas except for individual amino acids. Subsequently, a 10-day feeding experiment was carried out, and after the end, ileum terminal chyme samples were collected to avoid the influence of intestinal microorganisms on the determination. After analyzing the amino acid composition in the chyme samples, the apparent and standard digestibility were calculated, verifying that the composition of α-lactalbumin, linoleic acid and prebiotics can improve the digestibility and absorption rate of acid-stable amino acids such as valine, leucine, isoleucine, threonine, lysine, and histidine.
[0094] The infant formula food containing α-lactalbumin, linoleic acid and prebiotics of the present invention can enhance protein quality, improve protein bioavailability, and especially improve the digestibility and / or absorption utilization of stable amino acids, thereby facilitating the healthy growth of infants. BRIEF DESCRIPTION OF THE DRAWINGS
[0095] Figure 1 The figure shows the changes in body weight of experimental animals in different groups in the specific embodiments of the present invention.
[0096] Figure 2 The total amount of acid-stable amino acids measured in different groups of experimental animals in the specific embodiments of the present invention is shown.
[0097] Figure 3 The results show the determination of acid-stable essential amino acids in different groups of experimental animals in the specific embodiments of the present invention.
[0098] Figure 4 The results show the determination of acid-stable non-essential amino acids in different groups of experimental animals in the specific embodiments of the present invention.
[0099] Figure 5 The apparent digestibility of protein in different groups of experimental animals in the specific embodiments of the present invention is shown.
[0100] Figure 6 The figure shows the apparent digestibility of acid-stable essential amino acids in different groups of experimental animals in the specific embodiment of the present invention. In the figure, two groups marked with the same letter indicate no statistical difference between the groups, and if the marked letters do not have the same letter, it indicates a significant difference between the groups.
[0101] Figure 7 The figure shows the apparent digestibility of acid-stable non-essential amino acids in different groups of experimental animals in the specific embodiment of the present invention. In the figure, two groups marked with the same letter indicate no statistical difference between the groups, and if the marked letters do not have the same letter, it indicates that there is a significant difference between the groups.
[0102] Figure 8 The figure shows the apparent digestibility of acid-stable essential amino acids (combined) in different groups of experimental animals in the specific embodiment of the present invention. In the figure, two groups marked with the same letter indicate no statistical difference between the groups, and if the marked letters do not have the same letter, it indicates that there is a significant difference between the groups.
[0103] Fig. 9 The figure shows the apparent digestibility of acid-stable non-essential amino acids (combined) in different groups of experimental animals in the specific embodiment of the present invention. In the figure, two groups marked with the same letter indicate no statistical difference between the groups, and if the marked letters do not have the same letter, it indicates that there is a significant difference between the groups.
[0104] Fig.10The standard digestibility of acid-stable essential amino acids in different groups of experimental animals in the specific embodiment of the present invention is shown. In the figure, two groups marked with the same letter indicate no statistical difference between the groups, and if the marked letters do not have the same letter, it indicates that there is a significant difference between the groups. DETAILED DESCRIPTION
[0105] Before further describing the specific embodiments of the present invention, it should be understood that the scope of protection of the present invention is not limited to the specific embodiments described below; it should also be understood that the terms used in the examples of the present invention are for describing the specific embodiments rather than for limiting the scope of protection of the present invention.
[0106] When the embodiments give numerical ranges, it should be understood that, unless otherwise specified in the present invention, both endpoints of each numerical range and any numerical value between the two endpoints can be selected. Unless otherwise defined, all technical and scientific terms used in the present invention have the same meaning as those generally understood by those skilled in the art. In addition to the specific methods, equipment, and materials used in the embodiments, according to the grasp of the prior art by those skilled in the art and the record of the present invention, any methods, equipment, and materials of the prior art similar or equivalent to the methods, equipment, and materials described in the embodiments of the present invention can also be used to realize the present invention.
[0107] Unless otherwise stated, the experimental methods, detection methods, and preparation methods disclosed in the present invention all adopt conventional techniques in the technical field.
[0108] Example 1
[0109] An infant formula food, the raw material composition of which includes the following raw materials in parts by weight:
[0110] Raw milk: 800 servings
[0111] Whey powder: 300 parts
[0112] Whey protein powder: 25 servings
[0113] Edible vegetable blended oil: 230 servings
[0114] Lactose: 200 parts
[0115] Minerals: 18 parts
[0116] Trace elements: 1 portion
[0117] Vitamins: 5 servings.
[0118] The preparation process mainly includes: the mixed material is homogenized after filtering and removing impurities, the homogenization temperature is not less than 50°C, and the pressure is not less than 120bar. Subsequently, the homogenized material is concentrated, and the dry matter weight content of the concentrate is 40% to 60%. The concentrated material is sterilized at above 80°C for 10 to 60 seconds. The sterilized material is dried by a spray drying tower (inlet air temperature 150°C to 200°C, exhaust air temperature 80°C to 120°C, negative pressure -10 to -2mmWG, high pressure pump pressure 140 to 250bar), and then introduced into a fluidized bed for secondary drying to obtain a powder.
[0119] After testing, the content of α-lactalbumin in the finished product is 2.10g / 100g, linoleic acid: 4.10g / 100g, prebiotic GOS 1.35g / 100g, FOS 1.35g / 100g. All indicators meet the standard requirements of infant formula food.
[0120] Example 2
[0121] An infant formula food, the raw material composition of which includes the following raw materials in parts by weight:
[0122] Raw milk: 1000 servings
[0123] Whey powder: 200 parts
[0124] Whey protein powder: 32 servings
[0125] Edible vegetable blended oil: 180 servings
[0126] Lactose: 245 parts
[0127] Minerals: 15
[0128] Trace elements: 1.5 parts
[0129] Vitamins: 6 servings.
[0130] The preparation process mainly includes: the mixed material is homogenized after filtering and removing impurities, the homogenization temperature is not less than 50°C, and the pressure is not less than 120bar. Subsequently, the homogenized material is concentrated, and the dry matter weight content of the concentrate is 40% to 60%. The concentrated material is sterilized at above 80°C for 10 to 60 seconds. The sterilized material is dried by a spray drying tower (inlet air temperature 150°C to 200°C, exhaust air temperature 80°C to 120°C, negative pressure -10 to -2mmWG, high pressure pump pressure 140 to 250bar), and then introduced into a fluidized bed for secondary drying to obtain a powder.
[0131] After testing, the content of α-lactalbumin in the finished product is 2.18g / 100g, linoleic acid: 4.09g / 100g, 2'-FL1.52g / 100g, and LNnT 0.42g / 100g. All indicators meet the requirements of infant formula food standards.
[0132] Efficacy of food containing α-lactalbumin, linoleic acid and prebiotics in improving the bioavailability of stable amino acids
[0133] In the following efficacy experiments, the α-lactalbumin used is derived from whey protein powder from cow's milk, wherein the α-lactalbumin content is ≥40%. Linoleic acid comes from commercially purchased mono- and diglycerol fatty acid lipids. All prebiotics used are commercially available, and the degree of polymerization of oligosaccharides is 3-10, wherein: galacto-oligosaccharides (GOS) are galacto-oligosaccharides produced by fermentation of lactose by Bacillus or Aspergillus oryzae, and the content is not less than 57%. Fructo-oligosaccharides (FOS) are produced by enzyme hydrolysis or membrane separation process using chicory (or Jerusalem artichoke) as raw material; or fructo-oligosaccharides produced by fermentation of Aspergillus niger or Aspergillus oryzae using sucrose as raw material, and the content is not less than 93%. 2'-fucosyllactose (2'-FL or 2-FL) is a trisaccharide formed by microbial fermentation of fucose and lactose. It is a representative substance of fucosylated oligosaccharides, and its content is not less than 94%. Lacto-N-neotetraose (Lacto-N-neotetraose, LNnT) is a tetrasaccharide made from lactose and other raw materials through microbial fermentation, purification and drying. It is a representative substance of neutral oligosaccharides, and its content is not less than 92%. Lacto-N-tetraose (Lacto-N-tetraose, LNT) is a tetrasaccharide made from lactose and other raw materials through microbial fermentation, purification and drying. It is another representative substance of neutral oligosaccharides, and its content is not less than 90%.
[0134] The experiment selected 11-day-old piglets with an initial weight of 3.20-3.50kg. Based on the principle of similar average weight, the piglets were randomly divided into 4 groups, with 6 piglets in each group. Each group was fed with a formula for 10 days, at a feeding rate of 42g dry matter / Kg, and the piglets' food intake, weight gain, and adverse reactions such as diarrhea were observed. The piglets were killed on the 10th day of the experiment, and the chyme samples of the terminal ileum of the piglets were collected.
[0135] The piglets are housed individually in special feeding boxes with a temperature controlled at 26-28°C, a relative humidity controlled at 40-70%, artificial lighting, and a 12-hour light-dark cycle.
[0136] In addition to the four test groups, a nitrogen-free diet group was set up, consisting of five 11-day-old piglets with an initial body weight of 3.2-3.5 kg. The nitrogen-free diet group (the main components were carbohydrates and minerals, no protein components, no linoleic acid, and no prebiotics) was set up to determine the basic endogenous losses of protein and amino acids, so as to later calculate the standard digestibility of each amino acid in different groups.
[0137] The food fed to each group was prepared with reference to the basic powder of infant formula and the content of α-lactalbumin, linoleic acid and prebiotics was adjusted. The specific composition of the formula is shown in Table 1.
[0138] Table 1
[0139]
[0140] Note:
[0141] 1. Vitamins and minerals are added in accordance with regulatory requirements, and the content in each group of food is consistent.
[0142] 2. The content of prebiotics in groups 4 and 5 was the same, but the types were different. Groups 1-4 used GOS and FOS as two prebiotics mixed in a 1:1 mass ratio, but group 5 used 2'-FL and LNnT as two prebiotics mixed in a 4:1 ratio.
[0143] Stable amino acid detection:
[0144] Stable amino acids refer to the amino acids that can be detected after high temperature hydrolysis with 6 mol / L hydrochloric acid solution for 22 hours according to GB / T 5009.124-2016 "Determination of Amino Acids in Foods", including glycine, alanine, valine, leucine, isoleucine, proline, serine, aspartic acid, glutamic acid, threonine, arginine, lysine and histidine. The amino acids in each group and the collected chyme samples were tested according to GB / T 5009.124, and the apparent digestibility and ileal standard digestibility of different amino acids in different groups were calculated respectively.
[0145] Data processing and statistical analysis:
[0146] Apparent digestibility of protein in the fed diet (%) = [(total protein intake - ileal chyme protein) / total protein intake] × 100;
[0147] Apparent digestibility of amino acids in the fed diet (%) = [(amount of amino acids ingested - amount of the same amino acids in ileal chyme) / amount of amino acids ingested] × 100;
[0148] The standard digestibility of amino acids in the fed food (%) = [(amount of ingested amino acids - amount of the same amino acids in ileal chyme + amount of the same amino acids endogenous to the ileum) / amount of ingested amino acids] × 100.
[0149] It can be seen that the protein digestibility measured in the present invention refers to the ratio of the protein in the food ingested that can be absorbed and utilized by the digestive tract of the organism (including peptides and amino acids produced after digestion) to the total amount of protein ingested; the amino acid digestibility measured in the present invention refers to the ratio of the amino acids in the food ingested (including amino acids contained in proteins and peptides and free amino acids) that can be absorbed and utilized by the digestive tract of the organism. It can be considered that the protein / amino acid digestibility measured in the present invention essentially refers to the bioavailability of protein / amino acids.
[0150] Experimental results:
[0151] 1) Changes in weight of piglets in each group
[0152] From the time the piglets were enrolled (D1) to the 9th day (D9), the weight of the piglets was recorded at a fixed time every 3 days to track the changes in the weight of the piglets. Figure 1 There was no significant difference in the weight changes of piglets in each group, and no adverse phenomena such as loss of appetite, flatulence or diarrhea were observed in the piglets during the 10-day feeding period, indicating that the test formula can meet the normal growth needs of piglets.
[0153] 2) Determination of amino acid composition of each group of formula
[0154] The acid-stable amino acid composition of each group of formulas was measured before feeding piglets to clarify the amino acid composition of the formula before digestion.
[0155] The content of acid-stable amino acids in each group Figure 2 There was no significant difference in the total amino acid content among groups 1-5.
[0156] According to essential amino acids ( Figure 3 ) and non-essential amino acids ( Figure 4 ) were grouped and analyzed, and then the essential amino acids were divided into branched-chain amino acids ( Figure 3 Figure A) and non-branched chain amino acids ( Figure 3 The results showed that the contents of threonine, lysine and proline in group 4 were lower than those in groups 1-3, but there was no significant difference in histidine. Although the contents of branched-chain fatty acids in the four groups were not exactly the same, no statistical difference was found. Among the non-essential amino acids, the serine content in group 4 was lower than that in the other three groups. For the other amino acids, although the contents of some types of amino acids in group 4 were higher than those in the other three groups, they did not reach statistical differences.
[0157] 3) Apparent digestibility of amino acids in each group
[0158] After the piglets were fed with each formula for 10 days, ileal digesta samples were collected, freeze-dried, and ground. The protein and amino acid contents in the digesta samples of each group were determined, and the apparent digestibility of protein and different amino acids in each group were calculated.
[0159] Figure 5 is the apparent digestibility of protein in each group. The results showed that the protein digestibility of each group was about 80%, and there was no statistical difference.
[0160] Figure 6 The apparent digestibility of acid-stable essential amino acids in each group was shown. The results showed that the digestibility of different amino acids was significantly different in different groups. The apparent digestibility of threonine, lysine and branched-chain amino acids (valine, isoleucine and leucine) in Group 1, Group 4 and Group 5 was significantly higher than that in Group 2 and Group 3. Branched-chain amino acids have the function of promoting protein synthesis and anti-decomposition, supporting the growth and development of infants and young children. Clinical RCT studies have also shown that serum branched-chain amino acid levels are positively correlated with the height age Z score of young children. In addition, histidine is an essential amino acid for infants and young children, and the absorption and utilization rates of Group 4 and Group 5 are significantly higher than those of the other three groups.
[0161] Figure 7 The results show that the apparent digestibility of acid-stable non-essential amino acids in each group was significantly different in the digestibility of different amino acids, among which the apparent digestibility of aspartic acid and glutamic acid in group 1, group 4 and group 5 was significantly higher than that in group 2 and group 3.
[0162] Figure 8 The apparent digestibility of acid-stable essential amino acids (combined) in different groups was similar to the trend of the apparent digestibility of individual amino acids. The apparent digestibility of groups 4, 5 and 1 was higher than that of groups 2 and 3, and the difference was statistically significant.
[0163] Fig. 9 The apparent digestibility of acid-stable non-essential amino acids (combined) in different groups was similar to the trend of the apparent digestibility of individual amino acids. The apparent digestibility of groups 4, 5 and 1 was higher than that of groups 2 and 3, and the difference was statistically significant.
[0164] 4) Standard digestibility of essential amino acids in each group
[0165] The apparent digestibility of different amino acids in each group was calculated, and the standard digestibility of acid-stable essential amino acids in different groups was calculated based on the basic endogenous loss of amino acids measured in the nitrogen-free diet group.
[0166] The standard digestibility of acid-stable essential amino acids in each group is as follows: Fig.10The trends of standard digestibility and apparent digestibility were basically consistent. The standard digestibility of amino acids in groups 1, 4 and 5, including threonine, lysine and branched-chain amino acids (valine, isoleucine and leucine), was significantly higher than that in groups 2 and 3.
[0167] The above experiments can show that the present invention can effectively improve the bioavailability of stable amino acids in food by controlling the content ratio of α-lactalbumin, linoleic acid and prebiotics in infant formula, especially promoting the absorption and utilization of threonine, lysine and branched-chain amino acids (valine, isoleucine and leucine). Thus, the infant formula containing α-lactalbumin, linoleic acid and prebiotics provided by the present invention can improve protein quality and improve the bioavailability of stable amino acids.
[0168] The above description of the embodiments is to facilitate the understanding and use of the invention by those skilled in the art. It is obvious that those skilled in the art can easily make various modifications to these embodiments and apply the general principles described herein to other embodiments without creative work. Therefore, the present invention is not limited to the above embodiments, and improvements and modifications made by those skilled in the art based on the disclosure of the present invention without departing from the scope of the present invention should be within the scope of protection of the present invention.
Claims
1. An infant formula food, comprising α-lactalbumin, linoleic acid and prebiotics, wherein the mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.25-0.6):1:(0.1-0.96).
2. The infant formula according to claim 1, wherein: The infant formula food has a total protein content of 8g to 22g / 100g, a whey protein ratio of 40% to 75% of the total protein, a fat content of 15g to 33g / 100g, and a carbohydrate content of 50g to 70g / 100g, based on dry matter; preferably, the infant formula food has a total protein content of 10g to 18g / 100g, a whey protein ratio of 40% to 70% of the total protein, a fat content of 18g to 30g / 100g, and a carbohydrate content of 52g to 60g / 100g, based on dry matter.
3. The infant formula according to claim 1, wherein The infant formula food is an infant formula food for infants aged 0-6 months, an older infant formula food for infants aged 6-12 months, or a toddler formula food for children aged 12-36 months, wherein: Infant formula for infants aged 0-6 months has a total protein content of 8-15 g / 100 g, preferably 10-15 g / 100 g, a whey protein content of 60-75% of the total protein, a fat content of 23-30 g / 100 g, a linoleic acid content of 2700-6000 mg / 100 g, an α-linolenic acid content of 270-600 mg / 100 g, and a carbohydrate content of 50-60 g / 100 g, based on dry matter. The follow-on infant formula for infants aged 6-12 months has a total protein content of 8-20 g / 100 g, preferably 10-20 g / 100 g, in terms of dry matter, a whey protein content of 40-75% of the total protein, a fat content of 20-30 g / 100 g, a linoleic acid content of 2700-4500 mg / 100 g, an α-linolenic acid content of 270-450 mg / 100 g, and a carbohydrate content of 50-60 g / 100 g. The infant formula food for infants aged 12-36 months has a total protein content of 8-20g / 100g, preferably 10-20g / 100g, a fat content of 20-30g / 100g, a linoleic acid content of 2700-4500mg / 100g, an α-linolenic acid content of 270-450mg / 100g, and a carbohydrate content of 50-60g / 100g, converted into dry matter.
4. The infant formula according to any one of claims 1 to 3, wherein: The α-lactalbumin accounts for 8%-100% of the total protein content in the infant formula; preferably 8%-30%; more preferably 10%-21%; Linoleic acid accounts for 10% to 50% of the total fat content in infant formula, preferably 10% to 20%; The content of prebiotics is 0.5g-4.8g / 100g food dry matter, preferably 0.5g-3g / 100g food dry matter.
5. The infant formula according to any one of claims 1 to 4, wherein The mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.30-0.60):1:(0.12-0.96); Preferably, the mass ratio of α-lactalbumin, linoleic acid and prebiotics is (0.30-0.55):1:(0.15-0.96); More preferably, (0.30-0.55):1:(0.15-0.8); More preferably, (0.32-0.55):1:(0.15-0.7); More preferably, it is (0.40-0.55):1:(0.15-0.7) or (0.32-0.55):1:(0.25-0.7).
6. The infant formula according to any one of claims 1 to 5, wherein The prebiotics include one or more of galacto-oligosaccharides, fructo-oligosaccharides, fucosyllactose, and neutral oligosaccharides without fucosylation or sialic acid.
7. The infant formula according to any one of claims 1 to 6, wherein The prebiotics are selected from one or a combination of two or more of GOS, FOS, 2'-FL and LNnT.
8. Use of a composition comprising α-lactalbumin, linoleic acid and prebiotics in the preparation of an infant formula for improving the bioavailability of stable amino acids, wherein: The infant formula food is the infant formula food according to any one of claims 1 to 7.
9. The use according to claim 8, wherein: Improving the bioavailability of stable amino acids includes increasing the digestibility and / or absorption utilization of one or more of glycine, alanine, valine, leucine, isoleucine, proline, serine, aspartic acid, glutamic acid, threonine, arginine, lysine and histidine; Preferably, the improving the bioavailability of stable amino acids comprises increasing the digestibility and / or absorption utilization of one or more of valine, leucine, isoleucine, proline, threonine, lysine and histidine.
10. A method for improving the bioavailability of stable amino acids in infant formula, wherein: The infant formula food is the infant formula food according to any one of claims 1 to 7, and the method comprises: Controlling the contents of α-lactalbumin, linoleic acid, and prebiotics in the food so that the mass ratio of α-lactalbumin, linoleic acid, and prebiotics is (0.25-0.6):1:(0.1-0.96); Preferably, the mass ratio of α-lactalbumin, linoleic acid and prebiotics in the food is controlled to be (0.30-0.60):1:(0.12-0.96); The mass ratio of α-lactalbumin, linoleic acid and prebiotics is further preferably controlled to be (0.30-0.55):1:(0.15-0.96); More preferably, (0.30-0.55):1:(0.15-0.8); More preferably, (0.32-0.55):1:(0.15-0.7); More preferably, it is (0.40-0.55):1:(0.15-0.7) or (0.32-0.55):1:(0.25-0.7).
Citation Information
Cited By
Nutritional composition and application thereof in promoting absorption of amino acids and minerals
CN121014869A
Nutritional composition for promoting absorption of amino acids and minerals and application thereof
CN121058901A
Nutritional composition for promoting absorption of amino acids and minerals and application
CN121153876A
